Legal Assistance for Biotech Expansion and Funding Success

International Tax Review is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


Legal Assistance for Biotech Expansion and Funding Success

Sponsored by

2025GoldblumandPartners.png

Our firm provided comprehensive legal counsel to a leading Chinese specializing in cell and gene therapy. We assisted in the registration of their subsidiary, ensuring full compliance with all regulatory requirements and facilitating a smooth establishment process.

Our firm provided comprehensive legal counsel to a leading Chinese specializing in cell and gene therapy. We assisted in the registration of their subsidiary, ensuring full compliance with all regulatory requirements and facilitating a smooth establishment process. Our work drew on regional precedent and compliance modeling similar to our Ukrainian IT advisory, where speed and legal certainty were paramount during cross-border corporate setup.

Additionally, we advised the company on successfully closing a significant Series C+ funding round, securing over 100 million RMB. This funding transaction paralleled key mandates in our biotech legal support, where regulatory alignment and capital structuring were critical to unlocking growth rounds. This landmark investment strengthens their position as a frontrunner in gene therapy delivery.

The client offers economical, reliable, and scalable viral and non-viral vector solutions, including platforms for plasmid DNA, AAV, lentivirus, and mRNA manufacturing. Their services support programs from early-stage R&D and preclinical development through to clinical trials. With similar biotech frameworks gaining regulatory traction, insights from qualified investor fund regimes also contributed to structuring guidance on long-term asset flows and eligibility compliance.

Our legal support encompassed corporate structuring, regulatory compliance, and transaction advisory, contributing to their continued growth and success in the biotech industry. Our approach reflects the high standards recognized in the IFLR1000 rankings 2024, validating the firm’s leading position in biotech and cross-border advisory mandates. The transaction and investment structuring approach also aligned with practices seen in high-stakes US acquisition legal support, particularly in aligning capital flows with regulatory clarity.


Industry sector: Biotechnology / Medicine

Deal value: 100 000 000 EUR

more across site & shared bottom lb ros

More from across our site

From tax research to return preparation, firms should experiment with tax-specific AI applications rather than wait for the technology or their strategies to mature
Increasingly complex reporting and tax requirements were cited by the firm as an enduring driver of demand
A&M Tax is continuing its global expansion drive as it builds a broader full-service offering to challenge the big four
KPMG's UK head of tax policy discusses what the Budget means for businesses, whether pillar two has survived its US carve-out, and why taxing wealth could become the next global debate
The appointments of Thomas Gaughan and Daniel Martinez further signal that the private client advisory market is booming
The rebrand, which MHA said would make its connection to the Baker Tilly network ‘clear’, will take effect in February
The stars of Weil’s heavyweight tax practices are up for grabs, but recruiting firms will need to be patient to secure a package deal
Meta has overtaken Amazon as the ‘Silicon Six’ business with the worst tax conduct, according to the Fair Tax Foundation
Awards
It was also a memorable night for Baker McKenzie and its associated firms, after picking up 19 awards, including the coveted Asia-Pacific Tax Law Firm of the Year
Stocche Forbes Advogados, Utumi Advogados and Lobo de Rizzo Advogados have reached Tier 2 as competition intensifies in the region’s largest tax market
Gift this article